Expert Opinion on Biological Therapy [ISSN 1471-2598]; [e-ISSN 1744-7682] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers in biological therapy. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.

Expert Opinion on Biological Therapy aims to address the needs of scientists and managers in the healthcare and biopharmaceutical industries, and others closely involved in the development and application of biological therapies for the treatment of human disease.

Articles focus on the following key areas:

    Reviews covering therapeutic antibodies and vaccines, peptides and proteins, gene therapies and gene transfer technologies, cell-based therapies and regenerative medicine
    Drug evaluations reviewing the clinical data on a particular biological agent
    Original research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practice

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;

Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Biological Therapy, part of the Expert Collection brand.

EDITOR IN CHIEF
Michael Morse: Duke University Medical Centre, USA
EDITORIAL BOARD
Ivo Abraham: The University of Arizona, USA 
Mauro Alaibac: University of Padua, Italy 
Anthony Atala: Wake Forest Institute for Regenerative Medicine, USA 
Constantin Baxevanis: Saint Savas Cancer Hospital, Greece 
Alessandro Busca: San Giovanni Battista Hospital, Italy 
Laurent Peyrin-Biroulet: University Hospital of Nancy, France 
Cesar Borlongon: University of South Florida, USA 
George Calin: Anderson Cancer Center, USA 
Michele Caraglia: Seconda Universita degli Studi di Napoli, Italy 
Maria Castro: The University of Michigan School of Medicine, USA 
William Cho: Queen Elizabeth Hospital, Hong Kong 
Myron S Czuczman: Roswell Park Cancer Institute, USA 
Angus Dalgleish: St George's Hospital Medical School, UK 
Silvo Danese: Humanitas Research Hospital, Italy 
Constantin A Dasanu: University of California, USA 
Dwaine Emerich: InCytu Inc., USA 
Steven Feldman: Wake Forest School of Medicine, USA 
Arthur E Frankel: Scott & White Cancer Research Institute, USA 
Allan Goldstein: The George Washington University School of Medicine, USA 
Peter J Hudson: Avipep Pty Ltd., Australia 
David Kirn: Imperial College School of Medicine, UK 
Herwig Kollaritsch: Medical University of Vienna, Italy 
Robert Kreitman: National Cancer Institute, USA 
E Michael Lewiecki: University of New Mexico, USA 
M Alan Menter: Baylor University Medical Center, USA 
Alireza Minagar: Louisiana State University Health Sciences Center, USA 
Chi-Chiu Mok: University of Hong Kong, Hong Kong 
Gorka Orive: University of the Basque Country, Spain 
Ian Pringle: Trinity College, Oxford University, UK 
Nikolai Rainov: Martin Luther University Halle-Wittenberg, Germany 
Dario Sangiolo: IRCC - Institute for Cancer Research and Treatment, Italy 
Daniele Santini: University Campus Bio-Medico, Italy 
Susan Slovin: Memorial Sloan Kettering Cancer Center, USA 
Michael Vajdy: EpitoGenesis, Inc., USA 
Giovanni Vital e: University of Milan, Italy 
Heinz Wiendl: Universtiy of Munster, Germany